EP
Eversept Partners’s Ionis Pharmaceuticals IONS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Buy |
588,900
+71,879
| +14% | +$2.84M | 2.14% | 10 |
|
|
2025
Q1 | $15.6M | Buy |
517,021
+302,069
| +141% | +$9.11M | 1.58% | 22 |
|
|
2024
Q4 | $7.51M | Sell |
214,952
-256,403
| -54% | -$8.96M | 0.67% | 28 |
|
|
2024
Q3 | $18.9M | Buy |
471,355
+14,474
| +3% | +$580K | 1.29% | 19 |
|
|
2024
Q2 | $21.8M | Buy |
456,881
+80,443
| +21% | +$3.83M | 1.49% | 16 |
|
|
2024
Q1 | $16.3M | Buy |
376,438
+51,784
| +16% | +$2.24M | 1.09% | 18 |
|
|
2023
Q4 | $16.4M | Buy |
324,654
+72,208
| +29% | +$3.65M | 1.44% | 16 |
|
|
2023
Q3 | $11.5M | Buy |
252,446
+10,874
| +5% | +$493K | 0.97% | 20 |
|
|
2023
Q2 | $9.91M | Sell |
241,572
-61,797
| -20% | -$2.54M | 0.83% | 24 |
|
|
2023
Q1 | $10.8M | Buy |
303,369
+62,394
| +26% | +$2.23M | 0.76% | 27 |
|
|
2022
Q4 | $9.1M | Buy |
240,975
+39,142
| +19% | +$1.48M | 0.8% | 26 |
|
|
2022
Q3 | $8.93M | Buy |
201,833
+115,522
| +134% | +$5.11M | 0.77% | 26 |
|
|
2022
Q2 | $3.2M | Sell |
86,311
-72,495
| -46% | -$2.68M | 0.23% | 45 |
|
|
2022
Q1 | $5.88M | Sell |
158,806
-225,983
| -59% | -$8.37M | 0.45% | 41 |
|
|
2021
Q4 | $11.7M | Sell |
384,789
-65,712
| -15% | -$2M | 0.75% | 29 |
|
|
2021
Q3 | $15.1M | Buy |
450,501
+8,501
| +2% | +$285K | 1.05% | 25 |
|
|
2021
Q2 | $17.6M | Buy |
+442,000
| New | +$17.6M | 1.18% | 19 |
|